Skip to main content

Table 2 Association of high levels of cardiac fat (> median) with CVD and all-cause mortality

From: Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

Adipose tissue

Model

Composite (n = 248)

Men

Women

Composite (n = 191)

Composite (n = 57)

HR (95% CI)

p value

HR (95% CI)

p value

HR (95% CI)

p value

High EAT

1

1.46 (1.13; 1.88)

0.004

1.54 (1.15; 2.10)

0.004

1.22 (0.72; 2.06)

0.46

2

1.31 (1.01; 1.69)

0.038

1.40 (1.05; 1.87)

0.024

1.08 (0.63; 1.83)

0.79

3

1.32 (0.99; 1.78)

0.057

1.41 (1.01; 1.96)

0.041

1.16 (0.62; 2.17)

0.65

High PAT

1

1.07 (0.83; 1.37)

0.62

0.95 (0.72; 1.27)

0.46

1.22 (0.72; 2.07)

0.46

2

0.90 (0.70; 1.16)

0.42

0.83 (0.63; 1.10)

0.21

1.15 (0.67; 1.95)

0.62

3

0.84 (0.63; 1.12)

0.23

0.79 (0.57; 1.09)

0.16

1.05 (0.56; 1.97)

0.87

High CAT

1

1.20 (0.93; 1.54)

0.16

1.14 (0.86; 1.52)

0.43

1.24 (0.73; 2.10)

0.43

2

1.02 (0.79; 1.31)

0.88

1.00 (0.75; 1.33)

0.99

1.10 (0.64; 1.87)

0.73

3

0.97 (0.72; 1.30)

0.82

0.97 (0.69; 1.35)

0.86

1.04 (0.55; 1.98)

0.62

  1. HR values are presented according to high (> median) vs. low (< median) levels of adipose tissue
  2. Model 1 is unadjusted
  3. Model 2 is adjusted for age, sex
  4. Model 3 is adjusted for age, sex, LDL, diabetes duration, HbA1c, systolic blood pressure, smoking and BMI
  5. CI confidence interval, EAT epicardial adipose tissue, HR hazard ratio, PAT pericardial adipose tissue, CAT total cardiac adipose tissue